We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Prof. Tomris Ozben of Turkey Elected Next President of the IFCC

By LabMedica International staff writers
Posted on 04 Oct 2022

The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC, Milano, Italy) has announced the election of Prof. Tomris Ozben, representing the Turkish Biochemical Society (TBS), as its next President. In the election, Prof. Ozben received 45 votes (58%) from the 77 member societies that voted, out of a total of 89 member societies. Her term in office starts on January 2023 and is scheduled to end on December 2026. Other candidates in the election were Prof. Michael Neumaier (German Society for Clinical Chemistry and Laboratory Medicine; DGKL) and Prof. Tahir Pillay (South African Association for Clinical Biochemistry and Laboratory Medicine; SAACB).

Prof. Ozben, EuSpLM, Ph.D., D.Sc., and Specialist in Clinical Biochemistry, currently serves as President of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). She has been Chair or a Member in many Federations, Scientific Organizations, Societies, Committees and Councils. She is the Past-IFCC Treasurer, Past-Chair of the IFCC Congress and Conference Committee, Past-President of the Balkan Clinical Laboratory Federation (BCLF), and Board Member of the IFCC Foundation for Emerging Nations (FEN).

Over her tenure at Akdeniz University (Antalya, Turkey), Prof. Ozben has served as Vice Rector, Director of Research Funds, Chair of the Dept. of Clinical Biochemistry, and Founding Director of Central Laboratory at Akdeniz University Hospital. She worked for more than 10 years in the Ethical Committee of Akdeniz University Hospital and Medical Faculty on themes concerning drug research in clinical trials. She served as Commission Member of the Turkish Ministry of Health for restructuring Medical Education and Teaching, as well as Member-Elect of the Turkish High Educational Council for four years.

Prof. Ozben’s own research interests include identification of early markers for diagnosis and prognosis of cancer, cardiovascular and chronic kidney diseases, diabetes, liquid biopsy, proteomics, oxidative stress and antioxidants in health and disease, impact of apoptosis in cancer therapy, multidrug resistance, nanoparticles, therapeutic drug monitoring, development and validation of new tests, analytical techniques, quality control and management, teaching, mentoring, research, and laboratory management.

Prof. Ozben serves as mentor to numerous graduate students and takes part at Post-Graduate Education Programs (Specialty and PhD) at Akdeniz University, PhD program “Clinical Experimental Medicine” at University of Modena and Reggio Emilia and External Examiner for Post-graduate education at University of Zimbabwe. She has received several awards including Akdeniz University “Outstanding Service” and “Science” awards, AACC Van Slyke Society and AACC TDM/Toxicology Division and AACC’s National Academy of Clinical Biochemistry (NACB) awards.

Prof. Ozben is on the Editorial Board of several scientific journals, and a reviewer for several journals, and scientific projects evaluator for the Italian Ministry for University Education and Research (MIUR; CINECA), Ministry of Science and Environmental Protection of Republic of Serbia, Israel Science Foundation, and the Scientific and Technological Research Council of Turkey (TUBITAK). She has taken part in the organization of several WorldLabs, EuroMedLabs, IFCC General Conference, and FEBS-IUBMB Advanced Courses, Workshops and Young Scientists FORUMs. She has published over 250 manuscripts; several book chapters; edited books published by international publishers, and attended as an invited speaker to more than 300 international conferences.

Related Links:
IFCC 

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.